December 27, 2016 / 12:13 PM / 9 months ago

BRIEF-Shire announces FDA approval of Adynovate

Dec 27 (Reuters) - Shire Plc :

* FDA also approved adynovate for use in surgical settings for both adult and pediatric patients

* Shire announces FDA approval of Adynovate [antihemophilic factor (recombinant), pegylated] for use in children and surgical settings Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below